pharma
Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2
November 8, 2018Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin
A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …
Pharma stocks soar after US midterm elections
November 8, 2018Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market
Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …
FDA approves BMS’ multiple myeloma combo after it doubles progression-free survival
November 7, 2018Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Empliciti, FDA, US, multiple myeloma, pharma
The FDA has seen fit to approve Bristol-Myers Squibb’s Empliciti (elotuzumab) intravenous injection in combination with pomalidomide and dexamethasone for …
Lilly’s Trulicity reduces major cardiovascular events in “ambitious” trial of type 2 diabetes
November 7, 2018Research and Development Eli Lilly, Trulicity, cardiovascular events, pharma, type 2 diabetes
Eli Lilly has revealed new data on Trulicity (dulaglutide), showing that glucagon-like peptide-1 (GLP-1) receptor agonist achieved its primary endpoint …
UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres
November 6, 2018Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma
The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …
The November 2018 issue of Pharmafocus is available to read online now!
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, President trump, Trump, anti vaxxer, brexit, clinical trials, opioid crisis, opioids, pharma, vaccines
As the US continues to battle the demons in its healthcare system, Donald Trump looks like he may finally make …
FDA controversially approves potent opioid up to ten times stronger than fentanyl
November 6, 2018Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma
Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …
GSK’s anti-seizure drug shows promise in early depression study
November 2, 2018Medical Communications, Research and Development GSK, GlaxoSmithKline, Potiga, depression, pharma
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications …
Committee advises against FDA approval of Alkermes’ novel depression drug
November 2, 2018Medical Communications, Sales and Marketing Alkermes, FDA, depression, pharma
Alkermes has been knocked back with the disappointing, though not entirely unexpected, news that the FDA-appointed Psychopharmacologic Drugs Advisory Committee …
Galectin-3: The protein paving new treatment avenues
November 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma
Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …
Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal
November 1, 2018Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma
Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …
MSD’s Keytruda/chemo combo scores first-line FDA approval in NSC lung cancer
November 1, 2018Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
MSD’s blockbuster anti-PD-1 immunotherapy has secured another FDA approval, it has emerged, in combination with carboplatin and either paclitaxel or …
Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths
October 31, 2018Research and Development ITH Pharma, Metropolitan Police, NHS, pharma
An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …
AstraZeneca flogs two drug licenses in $922 million deal
October 31, 2018Research and Development, Sales and Marketing AstraZeneca, pharma
AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …
Common diabetes drug can protect against age-related macular degeneration, research shows
October 31, 2018Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma
A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
